IP Journal of Otorhinolaryngology and Allied Science
Official Publication of Khyati Education And Research Foundation
Official Publication of Khyati Education And Research Foundation
Print ISSN: 2582-4147
Online ISSN: 2582-421X
CODEN : IJOABK
IP Journal of Otorhinolaryngology and Allied Science (JOAS) open access, peer-reviewed quarterly journal publishing since 2018 and is published under the Khyati Education and Research Foundation (KERF), is registered as a non-profit society (under the society registration act, 1860), Government of India with the vision of various accredited vocational courses in healthcare, education, paramedical, yoga, publication, teaching and research activity, with the aim of faster and better dissemination of knowledge, we will be publishing the article more...Original Article
Author Details :
Volume : 3, Issue : 3, Year : 2020
Article Page : 81-85
https://doi.org/10.18231/j.ijoas.2020.018
Abstract
Upper respiratory tract infections (URTI) are one of the commonest cause for a patient’s visit to outpatient department (OPD). Short course therapies with penicillin and cephalosporin class of antibiotics are commonly prescribed in URTI cases. This study was a retrospective, multicentre, observational cohort analysis, planned to evaluate the effectiveness and safety of Cefixime 400 mg per day in patients of URTI, using WURSS 21 score. We analysed the data of 200 patients who were prescribed Cefixime for URTI. Most of the patients (55%) were male. The baseline mean WURSS score of 41.09 33.45 decreased to 25.74 22.29 [(-37.3%), p value<0> patients reported adverse effects. The findings of the present survey confirm the effectiveness and safety of short course of Cefixime therapy in URTI.
Keywords: URTI, Cefixime, WURSS, India.
How to cite : Pakhale K, Tandon G K, Bansal T, Jain V, Dhoot D, The efficacy and safety of Short course therapy with Cefixime in URTI in Indian Scenario. J Otorhinolaryngol Allied Sci 2020;3(3):81-85
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
